Ospemifene Pregnancy and Breastfeeding Warnings
Ospemifene is also known as: Osphena
Ospemifene Pregnancy Warnings
FDA pregnancy category: X Use of ospemifene is contraindicated.
Animal studies found embryofetal lethality, neonatal mortality, and difficult labor at maternally toxic doses. Animals given doses of 0.8% to 4% the human exposure based on surface area mg/m2, had prolonged and difficult gestation, increased post-implantation loss, increased number of offspring deaths, and an increased incidence of postnatal loss. The effect on fertility was not directly evaluated, but female animals experienced decreases in ovarian and uterine weights, decreased corpora lutea number, increased ovarian cysts, uterine atrophy, and disrupted cycles; and atrophy of the prostate and seminal vesicles was observed in male animals. There are no controlled data in human pregnancy. FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Ospemifene Breastfeeding Warnings
A nonclinical study detected ospemifene in animal milk at concentrations higher than in maternal plasma.
The manufacturer makes no recommendation regarding use during lactation. Excreted into human milk: Unknown Excreted into animal milk: Yes The effects in the nursing infant are unknown.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.